1. Home
  2. CCEL vs NEUE Comparison

CCEL vs NEUE Comparison

Compare CCEL & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • NEUE
  • Stock Information
  • Founded
  • CCEL 1989
  • NEUE 2015
  • Country
  • CCEL United States
  • NEUE United States
  • Employees
  • CCEL N/A
  • NEUE N/A
  • Industry
  • CCEL Managed Health Care
  • NEUE
  • Sector
  • CCEL Health Care
  • NEUE
  • Exchange
  • CCEL Nasdaq
  • NEUE NYSE
  • Market Cap
  • CCEL 51.9M
  • NEUE 57.1M
  • IPO Year
  • CCEL 1997
  • NEUE 2021
  • Fundamental
  • Price
  • CCEL $5.10
  • NEUE $6.65
  • Analyst Decision
  • CCEL Strong Buy
  • NEUE Hold
  • Analyst Count
  • CCEL 1
  • NEUE 1
  • Target Price
  • CCEL $8.50
  • NEUE $7.00
  • AVG Volume (30 Days)
  • CCEL 10.2K
  • NEUE 8.1K
  • Earning Date
  • CCEL 04-15-2025
  • NEUE 05-08-2025
  • Dividend Yield
  • CCEL 4.91%
  • NEUE N/A
  • EPS Growth
  • CCEL N/A
  • NEUE N/A
  • EPS
  • CCEL 0.01
  • NEUE N/A
  • Revenue
  • CCEL $32,102,750.00
  • NEUE $907,349,000.00
  • Revenue This Year
  • CCEL $2.49
  • NEUE $33.99
  • Revenue Next Year
  • CCEL $0.95
  • NEUE $5.90
  • P/E Ratio
  • CCEL $564.29
  • NEUE N/A
  • Revenue Growth
  • CCEL 2.33
  • NEUE N/A
  • 52 Week Low
  • CCEL $4.75
  • NEUE $3.79
  • 52 Week High
  • CCEL $9.50
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 38.95
  • NEUE 50.05
  • Support Level
  • CCEL $4.80
  • NEUE $6.66
  • Resistance Level
  • CCEL $5.76
  • NEUE $6.93
  • Average True Range (ATR)
  • CCEL 0.31
  • NEUE 0.22
  • MACD
  • CCEL -0.02
  • NEUE 0.00
  • Stochastic Oscillator
  • CCEL 29.24
  • NEUE 52.54

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Share on Social Networks: